1921
Volume 97, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

causes cutaneous leishmaniasis (CL) in Sri Lanka. Standard treatment is multiple, painful doses of intralesional sodium stibogluconate (IL-SSG). Treatment failures are increasingly reported, hence the need to investigate alternatives. Efficacy, safety, and cost-effectiveness of thermotherapy were assessed for the first time for . CL. A single blinded noninferiority randomized controlled trial was conducted on new laboratory-confirmed CL patients with single lesions ( = 213). Selected patients were randomly assigned to 1) test group ( = 98; single session of radiofrequency-induced heat therapy (RFHT) given at 50°C for 30 seconds) and 2) control group ( = 115; 1–3 mL IL-SSG given weekly, until cure/10 doses). Patients were followed-up fortnightly for 12 weeks to assess clinical cure. Cost of treatment was assessed using scenario building technique. Cure rates by 8, 10, and 12 weeks in RFHT group were 46.5%, 56.5%, and 65.9% as opposed to 28%, 40.8%, and 59.4% in IL-SSG group, with no major adverse events. Cure rate by RFHT was significantly higher at 8 weeks ( = 0.009, odds ratio [OR]: 2.236, confidence interval [CI]: 1.217–4.108) and 10 weeks ( = 0.035, OR: 1.881, CI: 1.044–3.388), but comparable thereafter. Cost of RFHT was 7 times less (USD = 1.54/patient) than IL-SSG (USD = 11.09/patient). A single application of RFHT is safe, cost-effective, and convenient, compared with multiple doses of IL-SSG in the treatment of CL. Therefore, RFHT would be considered noninferior as per trial outcome when compared with standard IL-SSG therapy with multiple benefits for the patient and the national health care system.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.16-0879
2017-10-11
2018-11-17
Loading full text...

Full text loading...

/deliver/fulltext/14761645/97/4/tpmd160879.html?itemId=/content/journals/10.4269/ajtmh.16-0879&mimeType=html&fmt=ahah

References

  1. Centers for Diease Control and Prevention, 2013. Parasites - Leishmaniasis: Epidemiology and Risk Factors. Available at: www.cdc.gov/parasites/leishmaniasis/index.html.
  2. Alvar J, Yactayo S, Bern C, , 2006. Leishmaniasis and poverty. Trends Parasitol 22: 552557.[Crossref]
  3. WHO, Control of the leishmaniasis, 2010. In Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Technical Report Series No 949. Geneva, Switzerland: World Health Organization, 1185.
  4. Kassi M, Afghan AK, Rehman R, Kasi PM, , 2008. Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLoS Negl Trop Dis 2: e259.[Crossref]
  5. Stewart CC, Brieger WR, , 2009. Community views on cutaneous leishmaniasis in Istalif, Afghanistan: implications for treatment and prevention. Int Q Community Health Educ 29: 123142.[Crossref]
  6. Berman JD, , 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24: 684703.[Crossref]
  7. Bryceson A, , 2001. A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop Med Int Health 6: 928934.[Crossref]
  8. Reithinger R, ., 2005. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 40: 11481155.[Crossref]
  9. Bumb RA, ., 2013. Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India. Br J Dermatol 168: 11141119.[Crossref]
  10. Aronson NE, ., 2010. A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis 4: e628.
  11. Karunaweera ND, , 2009. Leishmania donovani causing cutaneous leishmaniasis in Sri Lanka: a wolf in sheep’s clothing? Trends Parasitol 25: 458463.[Crossref]
  12. Karunaweera ND, Pratlong F, Siriwardane HVYD, Ihalamulla RL, Dedet JP, , 2003. Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37. Trans R Soc Trop Med Hyg 97: 380381.[Crossref]
  13. Karunanayake PH, Karunaweera ND, Siriwardana HVYD, , 2013. Management of leishmaniasis. Sri Lanka Prescriber 21: 15.
  14. Refai FW, Madarasingha N, Fernandopulle R, Karunaweera ND, , 2016. Nonresponsiveness to standard treatment in cutaneous leishmaniasis: a case series from Sri Lanka. Trop Parasitol 6: 48.
  15. Neva FA, Petersen EA, Corsey R, Bogaert H, Martinez D, , 1984. Observations on local heat treatment for cutaneous leishmaniasis. Am J Trop Med Hyg 33: 800804.[Crossref]
  16. Junaid AJ, , 1986. Treatment of cutaneous leishmaniasis with infrared heat. Int J Dermatol 25: 470472.[Crossref]
  17. Bloom DE, ., 1997. Socio-economic dimensions of the HIV/AIDS epidemic in Sri Lanka. Bloom DE, Godwin P, eds. The Economics of HIV and AIDS: The Case of South and South East Asia. Delhi, India: Oxford University Press.
  18. Garnier T, Croft SL, , 2002. Topical treatment for cutaneous leishmaniasis. Curr Opin Investig Drugs 3: 538544.
  19. Berman JD, Neva FA, , 1981. Effect of temperature on multiplication of Leishmania amastigotes within human monocyte-derived macrophages in vitro. Am J Trop Med Hyg 30: 318321.[Crossref]
  20. Travi BL, Osorio Y, Melby PC, Chandrasekar B, Arteaga L, Saravia NG, , 2002. Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp. Infect Immun 70: 22882296.[Crossref]
  21. Arana BA, Mendoza CE, Rizzo NR, Kroeger A, , 2001. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg 65: 466470.[Crossref]
  22. Safi N, , 2012. Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial. Int J Infect Dis 16: e174.[Crossref]
  23. Cardona-Arias JA, Vélez ID, López-Carvajal L, , 2015. Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials. PLoS One 10: e0122569.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0879
Loading
/content/journals/10.4269/ajtmh.16-0879
Loading

Data & Media loading...

  • Received : 08 Nov 2016
  • Accepted : 02 Jul 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error